Literature DB >> 22323583

Highly neurotoxic monomeric α-helical prion protein.

Minghai Zhou1, Gregory Ottenberg, Gian Franco Sferrazza, Corinne Ida Lasmézas.   

Abstract

Prion diseases are infectious and belong to the group of protein misfolding neurodegenerative diseases. In these diseases, neuronal dysfunction and death are caused by the neuronal toxicity of a particular misfolded form of their cognate protein. The ability to specifically target the toxic protein conformer or the neuronal death pathway would provide powerful therapeutic approaches to these diseases. The neurotoxic forms of the prion protein (PrP) have yet to be defined but there is evidence suggesting that at least some of them differ from infectious PrP (PrP(Sc)). Herein, without making an assumption about size or conformation, we searched for toxic forms of recombinant PrP after dilution refolding, size fractionation, and systematic biological testing of all fractions. We found that the PrP species most neurotoxic in vitro and in vivo (toxic PrP, TPrP) is a monomeric, highly α-helical form of PrP. TPrP caused autophagy, apoptosis, and a molecular signature remarkably similar to that observed in the brains of prion-infected animals. Interestingly, highly α-helical intermediates have been described for other amyloidogenic proteins but their biological significance remains to be established. We provide unique experimental evidence that a monomeric α-helical form of an amyloidogenic protein represents a cytotoxic species. Although toxic PrP has yet to be purified from prion-infected brains, TPrP might be the equivalent of one highly neurotoxic PrP species generated during prion replication. Because TPrP is a misfolded, highly neurotoxic form of PrP reproducing several features of prion-induced neuronal death, it constitutes a useful model to study PrP-induced neurodegenerative mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22323583      PMCID: PMC3286986          DOI: 10.1073/pnas.1118090109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  65 in total

1.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

Review 2.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

Authors:  Byron Caughey; Peter T Lansbury
Journal:  Annu Rev Neurosci       Date:  2003-04-09       Impact factor: 12.449

3.  Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli.

Authors:  J Buchner; R Rudolph
Journal:  Biotechnology (N Y)       Date:  1991-02

Review 4.  A 'unified theory' of prion propagation.

Authors:  C Weissmann
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

5.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

6.  A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions.

Authors:  P-C Klöhn; L Stoltze; E Flechsig; M Enari; C Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

7.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

8.  Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein.

Authors:  Claudio Hetz; Milene Russelakis-Carneiro; Kinsey Maundrell; Joaquin Castilla; Claudio Soto
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

9.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

10.  Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.

Authors:  Giovanna Mallucci; Andrew Dickinson; Jacqueline Linehan; Peter-Christian Klöhn; Sebastian Brandner; John Collinge
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

View more
  24 in total

1.  Unfolded protein response-induced ERdj3 secretion links ER stress to extracellular proteostasis.

Authors:  Joseph C Genereux; Song Qu; Minghai Zhou; Lisa M Ryno; Shiyu Wang; Matthew D Shoulders; Randal J Kaufman; Corinne I Lasmézas; Jeffery W Kelly; R Luke Wiseman
Journal:  EMBO J       Date:  2014-10-31       Impact factor: 11.598

2.  Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys.

Authors:  Pedro Piccardo; Juraj Cervenak; Ming Bu; Lindsay Miller; David M Asher
Journal:  J Gen Virol       Date:  2014-04-25       Impact factor: 3.891

3.  Single-molecule approaches to prion protein misfolding.

Authors:  Hao Yu; Derek R Dee; Michael T Woodside
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

4.  Thermodynamic characterization of the unfolding of the prion protein.

Authors:  Roumita Moulick; Jayant B Udgaonkar
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

5.  Comparing the energy landscapes for native folding and aggregation of PrP.

Authors:  Derek R Dee; Michael T Woodside
Journal:  Prion       Date:  2016-05-03       Impact factor: 3.931

6.  Regulating extracellular proteostasis capacity through the unfolded protein response.

Authors:  Joseph C Genereux; R Luke Wiseman
Journal:  Prion       Date:  2015       Impact factor: 3.931

7.  Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.

Authors:  Charles E Mays; Jacques van der Merwe; Chae Kim; Tracy Haldiman; Debbie McKenzie; Jiri G Safar; David Westaway
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

8.  Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.

Authors:  L Palanikumar; Laura Karpauskaite; Mohamed Al-Sayegh; Ibrahim Chehade; Maheen Alam; Sarah Hassan; Debabrata Maity; Liaqat Ali; Mona Kalmouni; Yamanappa Hunashal; Jemil Ahmed; Tatiana Houhou; Shake Karapetyan; Zackary Falls; Ram Samudrala; Renu Pasricha; Gennaro Esposito; Ahmed J Afzal; Andrew D Hamilton; Sunil Kumar; Mazin Magzoub
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 14.919

Review 9.  Alpha-synuclein modulates dopamine neurotransmission.

Authors:  Brittany Butler; Danielle Sambo; Habibeh Khoshbouei
Journal:  J Chem Neuroanat       Date:  2016-06-19       Impact factor: 3.052

Review 10.  Prions and Protein Assemblies that Convey Biological Information in Health and Disease.

Authors:  David W Sanders; Sarah K Kaufman; Brandon B Holmes; Marc I Diamond
Journal:  Neuron       Date:  2016-02-03       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.